Provision of Pharmacy Services
key details
| Value | £20,000,000 (£24,000,000 inc. VAT) |
|---|---|
| Status | planning |
| Category (CPV) | 33600000 +1 more |
| Region | London, South East |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-069a82 |
description
Kent Community Health NHS Trust (KCHFT) and Kent and Medway Mental Health NHS Trust (KMMH) are publishing this UK2: Preliminary Market Engagement Notice on 15th May 2026 to invite expressions of interest from suppliers to participate in a market engagement exercise relating to the provision of a complete pharmaceutical supply services for both inpatient and community services across the two Trusts.
Since 2022, Kent and Medway NHS Mental Health Trust (KMMH) and Kent Community Health NHS Foundation Trust (KCHFT) have collaboratively procured pharmacy services across both organisations. This joint approach builds on an established partnership, enabling a system-wide model that maximises the effective use of resources, strengthens local relationships, and enhances service delivery across both Trusts.
The overarching aim of the pharmacy supply service is to provide a safe, efficient, and patient-centred medicines supply function that supports high-quality clinical care across inpatient, rehabilitation, and community settings. The service is designed to:
| • | Ensure timely, accurate, and reliable dispensing and supply of medicines to meet the needs of patients and services. |
| • | Support safe and effective medicines management in line with legal, regulatory, and professional standards. |
| • | Enable continuity of care through responsive and flexible supply arrangements, including urgent and out-of-hours provision. |
| • | Reduce medicines waste and optimise resource utilisation through stock management, recycling, and redistribution processes. |
| • | Support digital transformation through integration with Electronic Prescribing and Medicines Administration (EPMA) systems. |
| • | Provide specialist services, including clozapine dispensing, in alignment with national monitoring requirements and local clinical pathways and the provision of over labelling of medicines. |
| • | Contribute to workforce development through the training and support of pre-registration/foundation pharmacists and pharmacy technicians. |
| • | Ensure robust financial and clinical governance through accurate data reporting, audit, and management of national medicines alerts. |
The service will work in partnership with clinical teams to ensure medicines optimisation, improve patient outcomes, and support the evolving needs of mental health and community healthcare services.
KCHFT will act as the lead authority for the procurement of these services.
An engagement presentation is scheduled for 10 am on 8th June 2026. This will be by Microsoft Teams and not in person.
The presentation will outline the Trusts' objectives for the service, anticipated timelines, and expectations for the procurement process. It will also provide an opportunity for suppliers to ask questions and offer feedback to the Trusts.
If you would like to participate in this session please email kentchft.procurementnotices@nhs.net to confirm attendance and an invite will be sent to you.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 15 May 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 045126-2026 |
more from KENT COMMUNITY HEALTH NHS FOUNDATION TRUST
- Model 51LCD - Bariatric Leg Ulcer Treatment Chair - Electric · 20 Jul 2026
- EICR Remedial Works for various locations · 1 Jul 2026
- Model 51LCD - Bariatric Leg Ulcer Treatment Chair - Electric · 1 Jul 2026
- Pest Control · £40,000 · 30 Jun 2026
- Cycle Courier Service For Dental · £20,000 · 22 Jun 2026
- iPad 11-inc,Power Adapter, Configuration Service, Screen Protector etc · 16 Jun 2026
- Samsung Galaxy S25 & Samsung Galaxy A17 · 16 Jun 2026
- Photographer and Videographer Services · £84,000 · 2 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.